RTC
MED icon

Riverview Trust Company’s Medifast MED Stock Holding History

Riverview Trust Company’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-321
Closed -$12.3K – 652
2024
Q1 		$12.3K Buy
+321
New +$15.5K 0.01% 621
2023
Q3 		– Sell
-156
Closed -$14.4K – 698
2023
Q2 		$14.4K Buy
+156
New +$13.9K 0.01% 554

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Riverview Trust Company's MED Position: Q2 2024 in Review

Riverview Trust Company sold out of Medifast (MED) in Q2 2024, closing a stake of 321 shares — an estimated $12.3K sold.

Riverview Trust Company first reported a position in MED in Q2 2023 and held it in 2 quarters. The position peaked at $14.4K in Q2 2023. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Riverview Trust Company reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Riverview Trust Company sold 321 Medifast shares in Q2 2024, an estimated $12.3K.
  • Riverview Trust Company first reported a position in Medifast in Q2 2023 and held it in 2 quarters.
  • Riverview Trust Company's Medifast position peaked at $14.4K in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Riverview Trust Company's 13F filing for Q2 2024, filed 16 Jul 2024.